FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1847729553> ?p ?o ?g. }

• W1847729553 endingPage "441" @default.
• W1847729553 startingPage "434" @default.
• W1847729553 abstract "Object Low-grade astrocytomas are slow-growing, infiltrative gliomas that over time may progress into more malignant tumors. Various factors have been shown to affect the time to progression and overall survival including age, performance status, tumor size, and the extent of resection. However, more recently it has been suggested that histological subtypes (fibrillary, protoplasmic, and gemistocytic) may impact patient outcome. In this study the authors have performed a large comparative population-based analysis to examine the characteristics and survival of patients with the various subtypes of WHO Grade II astrocytomas. Methods Patients diagnosed with fibrillary, protoplasmic, and gemistocytic astrocytomas were identified through the Surveillance, Epidemiology, and End Results (SEER) database. The chi-square test and Student t-test were used to evaluate differences in patient and treatment characteristics between astrocytoma subtypes. Kaplan-Meier analysis was used to assess overall survival, and the log-rank test was used to evaluate the differences between survival curves. Univariate and multivariate analyses were also performed to determine the effect of various patient, tumor, and treatment variables on overall survival. Results A total of 500 cases were included in the analysis, consisting of 326 fibrillary (65.2%), 29 protoplasmic (5.8%), and 145 gemistocytic (29%) variants. Gemistocytic astrocytomas presented at a significantly older age than the fibrillary variant (46.8 vs 37.7 years, p < 0.0001), with protoplasmic and fibrillary subtypes having a similar age. Although protoplasmic and fibrillary variants underwent radiotherapy at similar rates, gemistocytic tumors more frequently received radiotherapy (p = 0.0001). Univariate analysis revealed older age, larger tumor size, and the use of radiotherapy to be poor prognostic factors, with resection being associated with improved survival. The gemistocytic subtype (hazard ratio [HR] 1.62 [95% CI 1.27–2.07], p = 0.0001) also resulted in significantly worse survival than fibrillary tumors. Bivariate analyses demonstrated that older age, the use of radiotherapy, and resection significantly influenced median survival. Tumor subtype also affected median survival; patients who harbored gemistocytic tumors experienced less than half the median survival of fibrillary and protoplasmic tumors (38 vs 82 months, p = 0.0003). Multivariate analysis revealed increasing age (HR 1.05 [95% CI 1.04–1.05], p < 0.0001), larger tumor size (HR 1.02 [95% CI 1.01–1.03], p = 0.0002), and the use of resection (HR 0.70 [95% CI 0.52–0.94], p = 0.018) to be independent predictors of survival. Examination of tumor subtype revealed that the gemistocytic variant (HR 1.30 [95% CI 0.98–1.74], p = 0.074) was associated with worse patient survival than fibrillary tumors, although this only approached significance. The protoplasmic subtype did not affect overall survival (p = 0.33). Conclusions Gemistocytic tumor histology was associated with worse survival than fibrillary and protoplasmic astrocytomas. As protoplasmic astrocytomas have a survival similar to fibrillary tumors, there may be limited utility to the identification of this rare variant. However, increased attention should be paid to the presence of gemistocytes in low-grade gliomas as this is associated with shorter time to progression, increased malignant transformation, and reduced overall survival." @default.
• W1847729553 created "2016-06-24" @default.
• W1847729553 creator A5026450511 @default.
• W1847729553 creator A5064759816 @default.
• W1847729553 creator A5070064282 @default.
• W1847729553 creator A5075339542 @default.
• W1847729553 creator A5083472710 @default.
• W1847729553 date "2013-08-01" @default.
• W1847729553 modified "2023-10-02" @default.
• W1847729553 title "Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology" @default.
• W1847729553 cites W1509502448 @default.
• W1847729553 cites W1671390943 @default.
• W1847729553 cites W1822326383 @default.
• W1847729553 cites W1843877485 @default.
• W1847729553 cites W1855355791 @default.
• W1847729553 cites W1886614039 @default.
• W1847729553 cites W1996190316 @default.
• W1847729553 cites W2009265085 @default.
• W1847729553 cites W2010310350 @default.
• W1847729553 cites W2010423534 @default.
• W1847729553 cites W2013541155 @default.
• W1847729553 cites W2016919599 @default.
• W1847729553 cites W2020763802 @default.
• W1847729553 cites W2022508417 @default.
• W1847729553 cites W2028827431 @default.
• W1847729553 cites W2033918013 @default.
• W1847729553 cites W2036811161 @default.
• W1847729553 cites W2049801324 @default.
• W1847729553 cites W2059260164 @default.
• W1847729553 cites W2059995145 @default.
• W1847729553 cites W2066651153 @default.
• W1847729553 cites W2085918576 @default.
• W1847729553 cites W2091689466 @default.
• W1847729553 cites W2096946132 @default.
• W1847729553 cites W2116232743 @default.
• W1847729553 cites W2116693415 @default.
• W1847729553 cites W2119838967 @default.
• W1847729553 cites W2126525760 @default.
• W1847729553 cites W2134942438 @default.
• W1847729553 cites W2141570482 @default.
• W1847729553 cites W2147115032 @default.
• W1847729553 cites W2149436707 @default.
• W1847729553 cites W2161337626 @default.
• W1847729553 doi "https://doi.org/10.3171/2013.4.jns122329" @default.
• W1847729553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23662821" @default.
• W1847729553 hasPublicationYear "2013" @default.
• W1847729553 type Work @default.
• W1847729553 sameAs 1847729553 @default.
• W1847729553 citedByCount "31" @default.
• W1847729553 countsByYear W18477295532014 @default.
• W1847729553 countsByYear W18477295532015 @default.
• W1847729553 countsByYear W18477295532016 @default.
• W1847729553 countsByYear W18477295532017 @default.
• W1847729553 countsByYear W18477295532018 @default.
• W1847729553 countsByYear W18477295532019 @default.
• W1847729553 countsByYear W18477295532020 @default.
• W1847729553 countsByYear W18477295532021 @default.
• W1847729553 countsByYear W18477295532022 @default.
• W1847729553 countsByYear W18477295532023 @default.
• W1847729553 crossrefType "journal-article" @default.
• W1847729553 hasAuthorship W1847729553A5026450511 @default.
• W1847729553 hasAuthorship W1847729553A5064759816 @default.
• W1847729553 hasAuthorship W1847729553A5070064282 @default.
• W1847729553 hasAuthorship W1847729553A5075339542 @default.
• W1847729553 hasAuthorship W1847729553A5083472710 @default.
• W1847729553 hasBestOaLocation W18477295531 @default.
• W1847729553 hasConcept C10515644 @default.
• W1847729553 hasConcept C126322002 @default.
• W1847729553 hasConcept C126838900 @default.
• W1847729553 hasConcept C142724271 @default.
• W1847729553 hasConcept C144301174 @default.
• W1847729553 hasConcept C204232928 @default.
• W1847729553 hasConcept C2778227246 @default.
• W1847729553 hasConcept C2778880634 @default.
• W1847729553 hasConcept C2780495277 @default.
• W1847729553 hasConcept C38180746 @default.
• W1847729553 hasConcept C502942594 @default.
• W1847729553 hasConcept C509974204 @default.
• W1847729553 hasConcept C57742111 @default.
• W1847729553 hasConcept C71924100 @default.
• W1847729553 hasConceptScore W1847729553C10515644 @default.
• W1847729553 hasConceptScore W1847729553C126322002 @default.
• W1847729553 hasConceptScore W1847729553C126838900 @default.
• W1847729553 hasConceptScore W1847729553C142724271 @default.
• W1847729553 hasConceptScore W1847729553C144301174 @default.
• W1847729553 hasConceptScore W1847729553C204232928 @default.
• W1847729553 hasConceptScore W1847729553C2778227246 @default.
• W1847729553 hasConceptScore W1847729553C2778880634 @default.
• W1847729553 hasConceptScore W1847729553C2780495277 @default.
• W1847729553 hasConceptScore W1847729553C38180746 @default.
• W1847729553 hasConceptScore W1847729553C502942594 @default.
• W1847729553 hasConceptScore W1847729553C509974204 @default.
• W1847729553 hasConceptScore W1847729553C57742111 @default.
• W1847729553 hasConceptScore W1847729553C71924100 @default.
• W1847729553 hasIssue "2" @default.
• W1847729553 hasLocation W18477295531 @default.
• W1847729553 hasLocation W18477295532 @default.
• W1847729553 hasOpenAccess W1847729553 @default.

• next